NGBiLab S3.E6: Skinopathy

Based in Toronto, Ontario, Skinopathy is a medical technology company on a mission to provide accessible healthcare on demand. By integrating advanced AI with smartphone technology, Skinopathy allows patients to screen for skin cancer and other conditions from home, bridging the gap between early detection and specialized medical intervention.

In this episode, host Jim Wilson speaks with co-founder and CEO Keith Loo about the company’s "accidental" beginnings during the COVID-19 pandemic. What started as a conversation between friends about the alarming rise in late-stage skin cancer became a life-saving tool now used globally. Keith discusses the technical challenge of building AI that works on all skin tones, navigating Canadian healthcare bureaucracy, and the emotional weight of building a company that helps patients "cancel their funerals."

This conversation explores the intersection of high-tech innovation and human-centric care, highlighting how a tool meant to be given away for free evolved into a clinically validated platform that outperforms traditional diagnostic standards.

Note: We unfortunately ran into some technology issues with our microphone and apologize for Jim's mic quality. We have added a transcript to this podcast to make Jim's side accessible.